This Pre-Solicitation opportunity was posted on September 12, 2007. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

65-- FRESH FROZEN PLASMA AND FRESH FROZEN APHERESED PLASMA

Awarded

VA-256-07-RQ-0066Federal

Submission Closed09/20/2007, 05:00:00 AM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 621991

New

Federal

BPA - Blood Transfusion Services

Solicitation # FA860127Q0015

Solicitation FA8601-27-Q-0015 is a combined synopsis and request for quotation for a Blanket Purchase Agreement to provide blood components and reference laboratory transfusion testing services for Wright Patterson AFB, Ohio. The requirement is not set aside for small business concerns and falls under NAICS code 621991. The BPA has a master dollar limit of 425,000 dollars with a call limit of 85,000 dollars per order. The anticipated period of performance runs from December 4, 2026, through October 5, 2031, with deliverables required within 10 days after receipt of order. Award will be made based on the Lowest Price Technically Acceptable (LPTA) basis to the offeror who meets the technical capability requirements and provides the lowest fair and reasonable evaluated price. Mandatory requirements for submission include current SAM registration, a CMMC Level 1 certification recorded in the Supplier Performance Risk System, and the completion of a Required Information Sheet. Quotes must be submitted electronically to the designated contract specialists by October 29, 2026, at 4:00 PM EST. Shipping and acceptance are designated as FOB Destination.

POSTED

DEADLINE

Human Cadaver - Based Medical Training and Program Support Services for the 44th Medical Brigade stationed at Fort Bragg Army Base, North Carolina.

Solicitation # 0012468284

The Medical Acquisition Support Office – Alpha is seeking capable vendors to provide human cadaver-based medical training and program support for the 44th Medical Brigade. The scope of work includes the procurement and delivery of up to 20 ethically sourced, non-dissected perfused whole-body cadaver specimens annually, which must be serologically negative for HIV, Hepatitis B/C, and Syphilis. The contractor is responsible for providing refrigerated transportation to primary performance sites at Fort Bragg, NC; Fort Campbell, KY; Fort Stewart-Hunter Army Airfield, GA; and Fort Polk, LA. Additionally, the contractor must provide rental medical equipment and consumable Class VIII supplies, such as surgical packs, tourniquets, and simulated blood. The requirement includes providing highly qualified Subject Matter Experts (SMEs) to support up to 10 training events per fiscal year. These SMEs must be board-certified general surgeons with specific competencies in various trauma procedures, such as cricothyroidotomy and exploratory laparotomy, to serve as instructors and mentors. The anticipated contract structure consists of a base period followed by four one-year option periods. All personnel must comply with strict Installation Access Control System requirements, including Anti-Terrorism Level I and iWatch training, to gain access to military installations.

POSTED

DEADLINE

Cadaver Medical Training SupportThe Cadaver Medical Training Support subcontract, issued by the Department of Defense under W40M MRC0 West, involves providing technical and logistical assistance to prime contractors for medical training projects. The scope of work focuses on operational support for training days, specifically the preparation and management of cadavers utilizing specialized medical training lab equipment. The contract specifies a delivery requirement of 10 units of support and 10 training days per year. To ensure installation access, personnel are required to complete Anti-Terrorism Level I and iWatch training. This opportunity falls under NAICS code 621991 and is performed in the 78234 zip code area. Interested parties should note the response deadline of October 30, 2026.

POSTED

DEADLINE

6505--Human Blood and Blood Products

Solicitation # 36C25727Q0049

The Department of Veterans Affairs, Network Contracting Office 17, intends to award a single-award, firm-fixed-price Indefinite Delivery/Indefinite Quantity (IDIQ) contract to the South Texas Blood and Tissue Center. This procurement is for the supply and delivery of human blood and blood products, as well as guidance in clinical pathology procedures, to support the Audie L. Murphy Veterans Health Care Center within the South Texas Veterans Health Care System in San Antonio, Texas. The government is pursuing this as a sole source procurement under the authority of 41 U.S.C. 3304(a)(1) and FAR 6.103-1, asserting that only one responsible source can satisfy the agency's requirements. The contractor must maintain AABB and College of American Pathologists (CAP) accreditation and hold an unrevoked U.S. license from the FDA Bureau of Biologics. Key operational requirements include 24/7/365 availability and a tiered delivery system: STAT orders must be delivered within 60 minutes, ASAP orders within 2 hours, and routine orders within 24 hours. All products must be collected via closed systems under aseptic conditions, labeled according to the ABO Blood Group System and Rh type, and transported in compliance with FDA, AABB, and DOT regulations to ensure proper temperature maintenance. Acceptance of deliveries is based on STVHCS Blood Bank criteria, including physical appearance, contamination checks, and specific shelf-life minimums for red blood cells, plasma, and cryoprecipitate.

257-NETWORK Contract Office 17 (36C257)

POSTED

DEADLINE

Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)

Solicitation # RFA-CA-28-004

The National Cancer Institute (NCI) has issued a Limited Competition Notice of Funding Opportunity (RFA-CA-28-004) to support the continuation of two critical biospecimen banking resources: the National Clinical Trials Network (NCTN) Biobanks and the Early-Phase and Experimental Clinical Trials (EET) Biobank. The primary objective is to maintain these national resources for the collection, processing, storage, and distribution of high-quality, clinically annotated human biospecimens. These resources facilitate translational cancer research, biomarker development, and validation by providing essential specimens from NCI-funded clinical trials. The NCI intends to fund approximately six awards for fiscal year 2027, with a total estimated funding of 19 million dollars and a maximum budget of 3 million dollars in direct costs per year for a requested project period of six years. Applications will be evaluated through the NIH peer-review system based on scientific and technical merit, significance, and the adequacy of the institutional environment. Key requirements for applicants include maintaining active registrations in SAM, eRA Commons, and Grants.gov, as well as providing specific documentation regarding the current scale of operations, accomplishments, and standard operating procedures. Awardees must adhere to NCI Best Practices for Biospecimen Resources, federal human subjects regulations under 45 CFR 46, and strict cybersecurity incident reporting protocols, including notification of incidents within 48 hours of discovery. The scope of work includes managing secure informatics systems, providing specimen collection kits, and ensuring the availability of annotated biospecimens for authorized investigators.

National Institutes Of Health

POSTED

DEADLINE

Solicitation # RFA-CA-28-004

The National Cancer Institute is issuing a limited competition Notice of Funding Opportunity, solicitation RFA-CA-28-004, to support the continuation of two critical biospecimen banking resources. These resources include the National Clinical Trials Network Biobanks, which support the NCTN and the Community Oncology Research Program, and the Early-Phase and Experimental Clinical Trials Biospecimen Bank, which supports the ETCTN and other early-phase experimental trials. The primary objective is to maintain national infrastructure for the collection, processing, storage, and distribution of high-quality, clinically annotated human biospecimens to enable translational cancer research, biomarker development, and the study of drug response and resistance. Eligible organizations must submit applications by February 12, 2027, to be considered for funding. All submissions will undergo a standard NIH peer-review process, and only meritorious applications will be selected. These banks are essential for linking biospecimens to clinical outcome data from large multi-site trials and supporting the development of novel cancer therapies through pharmacokinetic and pharmacodynamic analyses.

National Cancer Institute

POSTED

DEADLINE

Kidney Transplant Exemption

Solicitation # 2139277

SUNY Downstate Health Sciences University has issued a notice for a single source exemption under solicitation number 2139277 to support its Kidney Transplant Program. This procurement action, which was posted on September 22, 2026, follows the approval of a CRER request by the Office of the State Comptroller on September 18, 2026. The scope of the procurement is specifically tied to the Kidney Transplant Unit having received a kidney for its program. The performance for this action is located at 450 Clarkson Avenue, Brooklyn, New York. As this is a notice of a procurement exempt from advertising, there are no competitive evaluation factors, listed contract terms, or specified contract values. The primary point of contact for this action is Purchase Associate Joanne Fraser.

State University of New York (SUNY)

POSTED

DEADLINE

Somatic Mosaicism across Human Tissues (SMaHT) Program: Tissue Procurement Center (R24 Clinical Trial Not Allowed)The National Institutes of Health is seeking a Tissue Procurement Center to support the Somatic Mosaicism across Human Tissues (SMaHT) Network. The primary goal of this initiative is to advance the understanding of biological processes and disease mechanisms driven by somatic mutations in human tissues. The center will be responsible for the collection, processing, storage, and distribution of high-quality human tissue specimens to enable functional analyses and the characterization of somatic mosaicism. The program aims to expand its existing foundation of 150 healthy donors by procuring tissues from at least 50 additional healthy individuals, reaching a total of 200. Additionally, the center will collect up to 10 special tissue cohorts, which may include clinically relevant samples, tissues suitable for culture, or organs requiring specialized handling. The awardee will collaborate with other SMaHT Stage 2 initiatives to ensure that all samples are sufficient for production-level assays.

National Institutes Of Health

POSTED

DEADLINE

Blood SamplesThe Department of Commerce is seeking to procure healthy GMP-grade Leukopaks and fresh healthy whole blood samples. These biological materials will be utilized for forensic DNA testing, the production of standard reference materials, the execution of inter-laboratory studies, and the publication of allele frequencies. This requirement is listed as a forecast with the place of performance located in Gaithersburg. The procurement falls under NAICS code 621991, and interested parties may coordinate with the designated point of contact, Daniel Dender, or the Office of Small and Disadvantaged Business Utilization.

POSTED

DEADLINE

Inpatient and Off-Site Facility CoordinationThis subcontract, titled Inpatient and Off-Site Facility Coordination, is issued by the Department of Justice under the agency Fao. The primary scope of work involves the arrangement and monitoring of off-site hospitalizations, diagnostic procedures, and specialty inpatient care, with a specific focus on managing the associated transport logistics. The contract is categorized under NAICS code 621991 and is designated for performance in Pine Knot, Kentucky, 42635. It was posted on August 14, 2026, and is available for further review through the official government workspace link.

POSTED

DEADLINE

Mobile Health Unit OperationsThe contract titled Mobile Health Unit Operations seeks a subcontractor to manage the operation and maintenance of mobile units tasked with delivering vision, dental, and hearing services to underserved communities across the region. These mobile units will serve as critical access points for essential health care, ensuring that populations with limited transportation or geographic barriers receive timely and consistent medical attention. The work involves the full lifecycle management of the units, including routine maintenance, repairs, staffing coordination, logistics, and compliance with health and safety standards to guarantee reliable service delivery. The contract is categorized as a subcontract under NAICS code 621991 and is solicited by the Houston-Galveston Area Council through the Texas SmartBuy platform. The solicitation was posted on July 22, 2026, with a response deadline of July 29, 2027, providing over a year for prospective vendors to prepare proposals. The place of performance spans the region served by the council, though exact locations are not specified, indicating flexibility in service deployment based on community need. While details on set-aside status and point of contact are unavailable, the focus remains on operational excellence and equitable access to preventive and diagnostic health services in areas lacking permanent clinical infrastructure.

HOUSTON-GALVESTON AREA COUNCIL

POSTED

DEADLINE

Continuation and Expansion of the National Mesothelioma Virtual Bank for Translational Research (U24)The National Mesothelioma Virtual Bank, managed by the Centers for Disease Control and Prevention under the Department of Health and Human Services, is a translational research initiative focused on advancing biomedical research for malignant mesothelioma. This forecast opportunity aims to expand the existing virtual registry and tissue bank by integrating additional biospecimens, such as frozen tumor tissues, blood, DNA, and protein samples, with comprehensive demographic and clinical data. By providing a shared repository of genomic, transcriptomic, and proteomic data, the project supports the identification of early disease signs, the development of prognostic biomarkers, and the creation of improved treatment options. The primary objective is to enhance the bank's capacity as a critical resource for the clinical science community and biomedical researchers. This effort is categorized under NAICS code 621991 and is designed to facilitate the sharing of high-quality specimens and data to accelerate breakthroughs in mesothelioma research.

Centers For Disease Control And Prevention

POSTED

3 months ago

DEADLINE

N/A

AI Contract Overview

The Michael E. DeBakey VA Medical Center is seeking a firm fixed price contract for the supply and delivery of Fresh Frozen Plasma and Fresh Frozen Apheresed Plasma to all participating facilities within VISN 16. All products must be typed for ABO and Rh Antigens and processed under aseptic conditions following FDA and American Association of Blood Banks standards. Strict quality controls are required, including mandatory testing for communicable diseases and negative Nucleic Acid Testing for HIV and Hepatitis C prior to shipment. Plasma must be free of hemolysis, excessive chyle, and clots, with expiration dates not exceeding nine months from the date of shipment. Eligible contractors must be registered and licensed with the FDA and the Department of Health and Human Services, providing proof of an unresolved U.S. License issued by the Bureau of Biologics. For interstate shipments, specific authorization under the Public Health Service Act is required. The selected contractor must adhere to strict delivery schedules determined by individual facilities and comply with all donor and packaging requirements outlined in the Statement of Work. This procurement is being conducted under the simplified acquisition procedures of the FAR Part 12 Subpart 13.5 Test Program.

General Info

Agency

N/A

Contract Value

$7,566

NAICS

621991 - Blood and Organ Banks

Place of Performance

VISN-wide,(VISN 16);Louisiana, MS, AR, TX, OK, 77030-4298, LA, USA

Set-Aside

NONE

Awardee

OKLAHOMA BLOOD INSTITUTE

Award Issued Date

01/01/2009, 12:00:00 AM UTC

Documents

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseAwarded

PostedSep 12

Presolicitation

AwardedJan 1

Contract was awarded

Submission Closed

09/20/2007, 05:00:00 AM UTC

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyN/A

ContactsNo contacts available

OfficeN/A

Organization / Agency

N/A

Office AddressN/A

ContactsNo contact information available

Full Description

The Michael E. DeBakey VA Medical Center, Houston, TX, intends to negotiate a VISN-wide firm fixed price contract for Fresh Frozen Plasma and Fresh Frozen Apheresed Plasma for the participating facilities in VISN 16. Contractor must be able to deliver the product to all participating facilities. Fresh Frozen Plasma shall be typed for ABO and Rh Antigens in accordance with methods recommended in the current edition of Standards for Blood Banks and Transfusion Services and the Technical Manual of the American Association of Blood Banks. Donor samples from each donation shall be tested with all tests for communicable disease as mandated by the FDA and required by the American Association of Blood Banks. Whole blood and components will not be used for transfusion unless the test is nonreactive. All blood is to be collected by the closed system under aseptic conditions and PLASMA is prepared and frozen under conditions and procedures mandated by the FDA and required by the American Assoc. of Blood Banks. Plasma shall be processed in appropriate solutions and container so labeled. The label shall also bear the expiration date of the contents which shall not exceed nine (9) months in advance when shipped. All blood supplied shall be grossly free of hemolysis, excessive chyle and clots. In addition all Fresh Frozen Plasma shall have been tested negatively utilizing Nucleic Acid Testing (NAT) for Human Immunodeficiency Virus (HIV) and Hepatitis C virus prior to shipment. Quotes will be considered only from contractors whose Blood Bank is currently registered and/or licensed with the FDA, Dept. of Health and Human Services pursuant to Section 510 of the FDA and Cosmetic Act, as amended, 21 USC Section 2760. Prior to award the contractor must submit proof that he holds an unresolved U.S. License which is issued by the Director, Bureau of Biologics, FDA under Section 351 of the Public Health Service Act, as amended, 42 USC Section 262, as a source of supply for whole blood. If interstate shipment of blood or blood components is involved, the contractor must submit with the quote a statement that such approval has been authorized under Section 262. The contractor certifies that he will comply with the donor requirements outlined with respect to donors, containers, delivery, etc. Detail Donor Requirement are provided in the Statement of Work in the Solicitation. Delivery schedules must be strictly adhered to as outlined in the Statement of Work. Each facility will issue a schedule as to their individual facility's need. Expiration Dates and Proper Packaging are also spelled out in the solicitation. In accordance with FAR Part 12, This procurement is being conducted under the Authority of Subpart 13.5 Test Program, utilizing the simplified acquisition procedures.